Skip to content

A single-blind, randomized, parallel-controlled, multicenter clinical trial was conducted to evaluate the efficacy and safety of an electric hemorrhoid stapler with disposable absorbable staples for the treatment of mixed hemorrhoids or grade ?–? internal hemorrhoids

A single-blind, randomized, parallel-controlled, multicenter clinical trial was conducted to evaluate the efficacy and safety of an electric hemorrhoid stapler with disposable absorbable staples for the treatment of mixed hemorrhoids or grade ?–? internal hemorrhoids

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600126011
Enrollment
Unknown
Registered
2026-06-02
Start date
2025-03-24
Completion date
Unknown
Last updated
2026-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemorrhoid

Interventions

Experimental group:Using the experimental electric hemorrhoid stapler produced by SURGAID MEDICAL (XIAMEN) CO.,LTD.
Control group:Using the already marketed electric anorectal stapler produced by SURGAID MEDICAL (XIAMEN) CO.,LTD.

Sponsors

Nanjing Hospital of Chinese Medicine affiliated to Nanjing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Meets the diagnostic criteria for mixed hemorrhoids or grades II to IV internal hemorrhoids as stipulated in the "Chinese Guidelines for the Diagnosis and Treatment of Hemorrhoids (2020 Edition)"; 2. Age 18 years or above and 65 years or below, with no gender restrictions; 3. Has surgical indications and is scheduled to undergo Tissue-Selecting Therapy Stapler (TST) surgery; 4. Has no severe liver or kidney dysfunction (ALT and/or AST are less than twice the upper limit of normal; serum creatinine and urea nitrogen are also less than twice the upper limit of normal); 5. BMI ranging from 18 to 30; 6. Has read the informed consent form in detail, fully understood this clinical trial, voluntarily participated in the trial and signed the informed consent form; All of the above conditions must be met simultaneously for inclusion.

Exclusion criteria

Exclusion criteria: 1. Pregnant women, women with pregnancy plans within 6 months, and their partners; breastfeeding women; 2. Those with severe heart or lung diseases, or those with other severe conditions; 3. Patients and their guardians cannot understand the requirements of participating in the study; 4. Uncontrolled mental disorders; 5. Clearly allergic to the metals used in the product; 6. Patients who have participated in other clinical trials before signing the informed consent but did not reach the study endpoint time limit or reached the study endpoint time limit but were less than 6 months; 7. Patients with pelvic floor dysfunction; 8. Patients who meet the contraindications of the product; 9. Other situations judged by the researcher as not suitable for inclusion. If any of the above conditions are met, the patient will not be eligible for inclusion.

Design outcomes

Primary

MeasureTime frame
Treatment effectiveness rate;

Secondary

MeasureTime frame
Evaluation of Absorption of Adhesive Screws;Evaluation of Anal Stenosis;Anus Function Score;Evaluation of the in-surgery operational performance of the product;Evaluation of anastomosis effect during surgery;

Countries

China

Contacts

Public ContactYehuang Wang

Nanjing Hospital of Chinese Medicine affiliated to Nanjing University of Chinese Medicine

wangyehuang@163.com+86 153 1204 5271

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026